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Giant coronary artery aneurysms (CAA), 
generally described as dilation that exceeds the 
reference vessel diameter by 4 times [1, 2], are 
a rare phenomenon and therefore the optimal 
management strategy in these clinical scenarios 
remains controversial without available evidence-
based guidelines. CAA treatment options may in-
clude conservative medical therapy, percutaneous 
coronary intervention (PCI), and surgical revas-
cularization [2]. Herein, is described the dilemma 
of managing an acute occlusion of a proximal left 
anterior descending artery (LAD) giant CAA, 
where each of the described treatment strategies 
were utilized in succession, ultimately leading to 
successful surgical intervention after the failure of 
less invasive medical and percutaneous methods.
A 50-year-old male was referred to the docu-
mented department after presenting high lat-
eral ST-segment elevation myocardial infarction 
(STEMI). Coronary angiography revealed diffuse 
atherosclerosis and aneurysmal coronary arter-
ies, notable for a giant proximal LAD coronary 
aneurysm with a hazy filling defect at the distal 
aneurysm edge and Thrombolysis in Myocardial 
Infarction (TIMI) grade 2 flow (Suppl. Movie 1). 
Left ventriculography confirmed the presence of an 
anterolateral wall motion abnormality (calculated 
left ventricular ejection fraction [LVEF] of 50%). 
Due to resolution of patient symptoms in the 
catheterization laboratory, in the context of angio-
graphic findings, intervention was deferred in favor 
of a conservative treatment strategy. The patient 
was treated with triple anti-thrombotic therapy in-
cluding acetylsalicylic acid (ASA), clopidogrel, and 
warfarin with a goal international normalized ratio 
(INR) of 2.0–3.0. Four months after discharge, war-
farin was switched to rivaroxaban (20 mg per day) 
because of persistent subtherapeutic INR levels.
The patient remained clinically well until 
10 months after his initial presentation, when he 
developed sudden-onset recurrent chest pain. 
Initial electrocardiogram (ECG) revealed an acute 
anterior STEMI. Emergency coronary angiography 
was performed within 6 h of symptom onset and 
demonstrated thrombotic occlusion of the proximal 
LAD inside the aneurysm (Fig. 1A). Left ventricu-
lography showed a new, severely reduced ejection 
fraction (calculated LVEF of 28%) with marked 
hypokinesis of the anterior segments. An urgent 
Heart Team meeting between interventional car-
diology and cardiac surgery was assembled, and 
a consensus decision was to proceed with primary 
angioplasty in the context of STEMI. Bolus IV 
heparin was given and the activated clotting time 
remained at > 350 s throughout the case indicat-
ing adequate systemic anticoagulation. Following 
engagement of the left main coronary artery with 
a 6 French EBU 4.0 guiding catheter, an intracoro-
nary abciximab bolus (0.25 mg/kg body weight) 
was immediately administered. The LAD occlu-
sion was crossed using a Sion blue wire (Asahi 
Intecc, Nagoya, Japan) with difficulty due to the 
aneurysmal sac. Primary angioplasty at the site 
of occlusion with a compliant balloon (RyujinTM 
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Plus, 2.0 × 15 mm, Terumo, Japan) restored TIMI 
grade 2 flow into the distal LAD. Of note, during 
coronary balloon inflation the distal funnel of the 
aneurysm was exposed, with a calculated 20° angle 
between the intra- and extra-aneurysm portions 
of the balloon inside the LAD (Fig. 1B, C). At this 
point, as the patient’s symptoms had resolved in 
the catheterization laboratory following success-
ful balloon angioplasty and, given angiographic 
findings showing a large thrombus burden inside 
Figure 1. Emergent coronary angiography demonstrated occlusion of the proximal left anterior descending artery 
(LAD) inside the aneurysm (A). The balloon inflation clearly revealed the distal funnel of the aneurysm: there was 
a 20° angle (arrow) between the intra-aneurysm portion and the extra-aneurysm portion of the balloon inside the 
LAD (B). Primary angioplasty at the site of occlusion restored Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow 
into the distal LAD (C). Six days later, a repeat coronary angiography confirmed partial regression of the thrombus 
in a patent LAD with TIMI grade 3 flow (D, E, F). Then, the Heart Team decision was to proceed with cardiothoracic 
surgery combining aneurysm exclusion and coronary artery bypass graft. During surgery the aneurysm was opened 
showing residual thrombus inside (arrowhead; G, H). Control coronary angiography revealed a total exclusion of the 
aneurysm (I) and final good result of the left internal mammary artery bypass grafting (J).
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the aneurysm, the treatment plan was to continue 
medical therapy followed by a re-look angiography 
5–7 days later. Dual antiplatelet therapy (ASA and 
clopidogrel) was continued, in addition to antico-
agulant therapy with IV unfractionated heparin. 
The patient remained stable on medical therapy 
in the Intensive Cardiac Care Unit, and underwent 
repeat coronary angiography 6 days after primary 
angioplasty demonstrating partial regression of 
the thrombus in a patent LAD with TIMI grade 
3 flow (Fig. 1D–F). The maximal diameter of the 
aneurysm exceeded 15.0 mm associated with 
a sac length of 60 mm by intravascular ultrasound 
imaging. Based on the size, the aneurysm did not 
appear amenable to PCI with commercially avail-
able polytetrafluoroethylene (PTFE)-covered 
stents. Thus, in consultation with the Heart Team, 
a surgical approach combining aneurysm exclusion 
and coronary artery bypass grafting (CABG) was 
recommended. On day 21, the patient underwent an 
uncomplicated on-pump single vessel CABG with 
bypass of the LAD using the left internal mam-
mary artery (LIMA). Intraprocedurally, the LAD 
coronary aneurysm (Fig. 1G, H) was released after 
transection of the pulmonary artery. The aneurysm 
was then opened and the proximal and the distal 
funnels were closed using a venous patch. Control 
coronary angiography revealed a total exclusion of 
the aneurysm (Fig. 1I) and good result of the LIMA 
bypass grafting (Fig. 1J). At 1-year follow-up, the 
patient remains asymptomatic with a stable ECG 
and LVEF of 38% assessed by cardiac magnetic 
resonance imaging.
In asymptomatic or stabilized patients with 
CAA thrombosis, several case reports have high-
lighted various successful conservative treatment 
strategies [2, 3]. At present, the role of direct 
oral anticoagulants for long-term treatment of 
CAA is currently unknown. Medically managed 
patients likely require lifelong therapy, as they are 
potentially at high risk for recurrent thrombosis 
should anti-thrombotic treatment be interrupted 
[2]. However, in patients presenting with STEMI, 
emergent PCI should be considered [4], optimally 
in the context of a Heart Team decision-making 
approach. Percutaneous exclusion of the CAA with 
one or many overlapped PTFE-covered stents 
may be of value in select patients with “short” 
aneurysms that are less than 10 mm in diameter 
located in straight, large proximal vessels [5, 6]. 
Furthermore, anatomical suitability should be con-
sidered carefully before covered stent use, as many 
of these devices require large, supportive guides 
and guidewires among other techniques to en-
hance delivery [7]. Recently, Boi et al. [8] reported 
a promising technique consisting of two different 
layers of overlapping stents named “double-layer 
bridging”. Use of spirals to obtain aneurysm throm-
bosis is sometimes useful [9]. Patients presenting 
with CAA involving the left main coronary artery, 
bifurcation of significant side branch vessel le-
sions, multivessel coronary artery disease, giant 
aneurysms [10], or a separate indication for car-
diothoracic surgery unrelated to CAA are usually 
referred for surgical revascularization. Although 
this case report does not correspond exactly to 
these criteria, the present Heart Team considered 
that surgical revascularization was the most ap-
propriate strategy for favorable long-term outcome 
of the patient in the context of the large aneurysm 
dimensions, significant thrombus burden, and the 
high rate of target lesion revascularization associ-
ated with the use of a covered stent.
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